Doctor profile · Federal record
Dr. MALAZ ALMSADDI, M.D.
Neurology Physician (CMS: NEUROLOGY) · Sleep Medicine (Psychiatry & Neurology) Physician · BLOOMFIELD HILLS, MI
- NPI 1003897562
- Accepts Medicare
- MIPS 82.3 / 100 · 2023
- 38 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2525 S TELEGRAPH RD, SUITE 200
BLOOMFIELD HILLS, MI 483020288
(248) 451-1466
fax (248) 451-1467
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- January 18, 2021
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Michigan #4301091349
- Medicaid
- MI #1003897562
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1003897562. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,254
Distinct HCPCS
10
Medicare allowed
$244,769
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,084 | 212 | $82 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 380 | 199 | $129 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 244 | 216 | $135 | |
95819 |
Measurement of brain wave activity (eeg), awake and asleep | 154 | 138 | $57 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 69 | 69 | $170 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 64 | 47 | $93 | |
95819 |
Measurement of brain wave activity (eeg), awake and asleep | 59 | 57 | $437 | |
95886 |
Needle measurement of electrical activity in arm or leg muscles, complete study | 59 | 29 | $97 | |
95886 |
Needle measurement of electrical activity in arm or leg muscles, complete study | 38 | 18 | $46 | |
95911 |
Nerve conduction, 9-10 studies | 22 | 21 | $212 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 101. This provider delivers 22× the peer median.Open Payments
Industry payments received
All-time total
$4,588
Transactions
199
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| UCB, Inc. | 37 | $466.91 | |
| CATALYST PHARMACEUTICALS, INC. | 13 | $286.02 | |
| Neurocrine Biosciences, Inc. | 13 | $251.86 | |
| JAZZ PHARMACEUTICALS INC. | 14 | $238.06 | |
| Sumitomo Pharma America, Inc. | 21 | $214.74 | |
| ARGENX US, INC. | 12 | $213.96 | |
| SK Life Science, Inc. | 10 | $186.18 | |
| PFIZER INC. | 13 | $178.65 | |
| Novartis Pharmaceuticals Corporation | 14 | $175.80 | |
| Alnylam Pharmaceuticals Inc. | 9 | $165.62 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $163.53 | |
| ABBVIE INC. | 12 | $148.30 | |
| Neurelis, Inc. | 10 | $146.89 | |
| Celgene Corporation | 8 | $146.80 | |
| Otsuka America Pharmaceutical, Inc. | 8 | $144.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,540
Patients
532
Total drug cost
$230,916
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Memantine Hcl | Generic | 529 | 119 | $25,373 |
| Gabapentin | Generic | 277 | 69 | $5,914 |
| Levetiracetam | Generic | 275 | 58 | $19,433 |
| Donepezil Hcl | Generic | 221 | 46 | $3,385 |
| Lacosamide | Generic | 195 | 25 | $32,563 |
| Topiramate | Generic | 156 | 28 | $3,935 |
| Quetiapine Fumarate | Generic | 131 | 28 | $3,750 |
| Primidone | Generic | 128 | 32 | $3,406 |
| Clonazepam | Generic | 115 | 21 | $581 |
| Carbidopa-Levodopa Er (Carbidopa/Levodopa) | Brand | 102 | 20 | $9,554 |